# QUILLIVANT XR
> **NDA202100** · New Drug Application · Sponsor: NEXTWAVE · Approved 2012-09-27
## Drug
- **FDA Application Number:** NDA202100
- **Application type:** New Drug Application
- **Brand name:** QUILLIVANT XR
- **Generic name:** METHYLPHENIDATE HYDROCHLORIDE
- **Active ingredients:** METHYLPHENIDATE HYDROCHLORIDE
- **Dosage form:** FOR SUSPENSION, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** NEXTWAVE
- **Manufacturer:** NextWave Pharmaceuticals, Inc
- **First approval:** 2012-09-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202100)
---
*AI Analytics · CC0 1.0*